NCT07148414: A Study of SPY072 in Rheumatic Disease
- State
- Under way
- Phase
- Phase 2
- People
- 285 planned
- Started
- 21 Aug 2025
- Primary completion
- 31 Oct 2026
- Arms
- Rheumatoid Arthritis, Dose Regimen 1, Rheumatoid Arthritis, Dose Regimen 2, Psoriatic Arthritis, Axial Spondyloarthritis
- Results
- None posted
- 21 Aug 2025: Trial started
- 29 Aug 2025: Trial registered